TOKYO - Japan took steps Saturday to fast-track its approval of the anti-viral drug remdesivir for the treatment of new coronavirus patients, as the domestic death toll topped 500 including cases from a cruise ship.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
